IUGNF
IMUGENE LTD ORD by Imugene, Ltd. (IUGNF)
$20
About IMUGENE LTD ORD by Imugene, Ltd. (IUGNF)
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.44
52 Week Low
$0.01
Market cap
68.2M
Dividend yield
0.00%
Volume
--
Avg. volume
9,752
P/E ratio
-1.05
IMUGENE LTD ORD by Imugene, Ltd. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.44
52 Week Low
$0.01
Market cap
68.2M
Dividend yield
0.00%
Volume
--
Avg. volume
9,752
P/E ratio
-1.05